Clinical studies recruiting near Providence

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors
Phase 1 · Erasca, Inc. · NCT06983743 A Study to Investigate the Safety and Efficacy of MEDI0618 Compared to Placebo in Adult Participants With Episodic Migra
Phase 2 · AbbVie · NCT06602479 A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Phase 3 · Eli Lilly and Company · NCT07218380 Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2
Phase 3 · Joseph Broderick, MD · NCT07227246 A Study of JNJ-86974680 in Participants With Advanced Non-small Cell Lung Cancer
Phase 1 · Johnson & Johnson Enterprise Innovation Inc. · NCT06116786 Alpha-1 Blockade for Alcohol Use Disorder (AUD)
Phase 2 · Brown University · Brown University · NCT04135846 A Clinical Trial of Combination HIV-Specific Broadly Neutralizing Monoclonal Antibodies Combined With ART Initiation Dur
Phase 2 · 2951, The Miriam Hospital (TMH) CRS · National Institute of Allergy and Infectious Diseases (NIAID · NCT05719441 A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line
Phase 3 · Merck Sharp & Dohme LLC · NCT06136559 AVA6103 in Subjects With Locally Advanced or Metastatic Selected Solid Tumors
Phase 1 · Avacta Life Sciences Ltd · NCT07454642 Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
Phase 3 · Merck Sharp & Dohme LLC · NCT06393374 MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Wi
Phase 2 · Rhode Island Hospital · National Cancer Institute (NCI) · NCT05564390 Phase Ib Trial of Multivalent Autophagosome Vaccine With or Without GITR Agonist, With Anti-PD-1 Immunotherapy in HNSCC
Phase 1 · Providence Health & Services · NCT04470024 A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) G
Phase 1/Phase 2 · Rhode Island Hospital · National Cancer Institute (NCI) · NCT05099003 The MIRROR Registry: Minimally Invasive IntRaceRebral HemORrhage Evacuation
Phase N/A · Integra LifeSciences Corporation · NCT04494295 A Phase III Trial of BNT324 Versus Docetaxel in Metastatic Castration-resistant Prostate Cancer
Phase 3 · BioNTech SE · NCT07365995 This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in
Phase 3 · Pfizer · NCT06758401 Study of XB010 in Subjects With Solid Tumors
Phase 1 · Exelixis · NCT06545331 A Study of IDE849 in Patients With DLL3 Expressing Tumors Including Small Cell Lung Cancer
Phase 1/Phase 2 · IDEAYA Biosciences · NCT07174583 Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed
Phase 3 · Rhode Island Hospital · National Cancer Institute (NCI) · NCT06172296 Combined Oral Motor Stimulation and Language on Preterm Infant Feeding
NA · Women & Infants NICU · Women and Infants Hospital of Rhode Island · NCT05861531 Trial of Nab-Sirolimus in Combination With Letrozole in Patients With Advanced or Recurrent Endometrioid Endometrial Can
Phase 2 · Women & Infants Hospital · Aadi Bioscience, Inc. · NCT05997017 Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small C
Phase 3 · NRG Oncology · NCT05624996 A Study to Learn About the Study Medicine (Called PF-07868489) in People With Pulmonary Arterial Hypertension Who Have P
Phase 2 · Rhode Island Hospital · Pfizer · NCT07073820 A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
Phase 1 · Seagen, a wholly owned subsidiary of Pfizer · NCT05208762 A Study of STM-416 Administered to Patients Undergoing TURBT for Recurrent Bladder Cancer
Phase 1/Phase 2 · SURGE Therapeutics · NCT05710848 Treatment With Endovascular Intervention for STroke Patients With Existing Disability
Phase N/A · University of Cincinnati · NCT05911568 PRE-EMPT: Prospective RandomizEd Evaluation and Management of Premature aTherosclerosis
Phase 3 · Duke University · NCT07232069 A First-in-human Dose Escalation and Expansion Study to Evaluate the Safety, and Tolerability of AZD8421 Alone or in Com
Phase 1/Phase 2 · Research Site · AstraZeneca · NCT06188520 A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic Cancer
Phase 2 · Verastem, Inc. · NCT07644559 A Phase 1, First in Human Study of TORL-4-500 in Patients With Advanced Cancer
Phase 1 · TORL Biotherapeutics, LLC · NCT06005740

Look up another city

Look up another condition